TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12535740

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: DM group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: HC group
Number of subjects: 90
Study: 15613223

Group type: EXPERIMENTAL
Intervention: Rizatriptan 5 mg tablet during migraine (n=18)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Rizatriptan 5 mg tablet in migraine-free state (n=21)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo during migraine (n=3)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo in migraine-free state (n=21)
Number of subjects: 21
Study: 8877276

Group type: EXPERIMENTAL
Intervention: Acute metformin administration (850 mg single dose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chronic metformin treatment (850 mg twice a day for a month)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 1792618

Group type: EXPERIMENTAL
Intervention: nifedipine (30‐60 mg/day)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: aldizem (180‐270 mg/day)
Number of subjects: 46
Study: 3011583

Group type: EXPERIMENTAL
Intervention: Low-dose aluminum-magnesium antacid regimen (Link one tablet q.i.d.)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: High-fiber diet
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Low-fiber diet
Number of subjects: 86
Study: 31728609

Group type: EXPERIMENTAL
Intervention: GEWF solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carnoy solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 0
Study: 30125815

Group type: EXPERIMENTAL
Intervention: Video animations with different frames conveying messages about recycled water safety
Number of subjects: 689

Group type: EXPERIMENTAL
Intervention: Safety message framed in terms of the selection of water treatment technology to remove contaminants
Number of subjects: 689

Group type: EXPERIMENTAL
Intervention: Safety message framed in terms of non-potable water risks relative to other everyday risks
Number of subjects: 689
Study: 27912960

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: No music intervention
Number of subjects: 31
Study: 24618485

Group type: EXPERIMENTAL
Intervention: Porous polyethylene implant with mucus membrane graft (MMG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dermis fat graft (DFG)
Number of subjects: 24
Study: 22978720

Group type: EXPERIMENTAL
Intervention: Cigarette smoke particulate matter (PM) exposure in vitro
Number of subjects: 5

Group type: COMPARATOR
Intervention: Cigarette smoking cessation for 5 days
Number of subjects: 5
Study: 20545210

Group type: EXPERIMENTAL
Intervention: Qianliening Tang (QLNT), daily potion, two times a day for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Qianliekang, three times a day, three pills each time for 8 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy group (group C)
Number of subjects: 0
Study: 22791754

Group type: COMPARATOR
Intervention: hCG 0 IU/day (D0)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: hCG 50 IU/day (D50)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: hCG 100 IU/day (D100)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: hCG 150 IU/day (D150)
Number of subjects: 62
Study: 15745836

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study: 12752555

Group type: EXPERIMENTAL
Intervention: Histamine challenge
Number of subjects: 23

Group type: COMPARATOR
Intervention: Saline lavage
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Histamine challenge in COPD patients with nasal symptoms
Number of subjects: 23
Study: 9467046

Group type: EXPERIMENTAL
Intervention: 0.25 microgram/kg recombinant human interleukin-4
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 1.0 microgram/kg recombinant human interleukin-4
Number of subjects: 63
Study: 7699303

Group type: EXPERIMENTAL
Intervention: Individually supervised physical activity program (2 sessions of 90 minutes each for 10 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Equal individualized attention through extra academic instruction (Control group)
Number of subjects: 45
Study: 2496671

Group type: EXPERIMENTAL
Intervention: Protective isolation (private room, hat, mask, sterile gown, handwashing)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No isolation (crowded, open intensive care unit)
Number of subjects: 60
Study: 782463

Group type: EXPERIMENTAL
Intervention: Combination therapy with naproxen and aspirin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 36

Group type: COMPARATOR
Intervention: Naproxen and placebo
Number of subjects: 36
Study: 30690848

Group type: EXPERIMENTAL
Intervention: Implant-level (IL) FPD
Number of subjects: 50

Group type: COMPARATOR
Intervention: Abutment-level (AL) FPD
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both IL and AL FPD
Number of subjects: 50
Study: 28765681

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 38

Group type: COMPARATOR
Intervention: Olanzapine (Control)
Number of subjects: 38
Study: 25395191

Group type: EXPERIMENTAL
Intervention: Zolmitriptan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23782591

Group type: EXPERIMENTAL
Intervention: Acetylcholinesterase inhibitors (ChEI) including donepezil, rivastigmine, and galantamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy Aging Brain Care Monitor and Neuropsychiatric Inventory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacogenomic signatures evaluation
Number of subjects: 0
Study: 22174580

Group type: EXPERIMENTAL
Intervention: ARB/CCB/HCTZ (valsartan/amlodipine 160/5 mg + HCTZ 25 mg)
Number of subjects: 84
Study: 18490561

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 100
Study: 16543688

Group type: EXPERIMENTAL
Intervention: ACE inhibitor (benazepril 1.25 to 5 mg daily or trandolapril 0.5 to 4 mg daily)
Number of subjects: 68

Group type: COMPARATOR
Intervention: ARB (candesartan 2 to 8 mg daily or losartan 25 to 100 mg daily)
Number of subjects: 68

Group type: COMPARATOR
Intervention: ACE inhibitor
Number of subjects: 68

Group type: COMPARATOR
Intervention: ARB
Number of subjects: 68
Study: 14633812

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/day)
Number of subjects: 1031

Group type: EXPERIMENTAL
Intervention: Vitamin E (300 mg/day)
Number of subjects: 1031

Group type: COMPARATOR
Intervention: Control group (no aspirin or vitamin E)
Number of subjects: 1031
Study: 10990044

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 0.1%/gentamicin 0.3% drops 4X/day until day 12-14 and diclofenac sodium 0.1% 3X/day until day 28
Number of subjects: 87

Group type: COMPARATOR
Intervention: Dexamethasone phosphate 0.1% drops 4X/day until postoperative day 12-14 and 3X/day until day 28 and gentamicin 0.3% drops 4X/day until day 12-14
Number of subjects: 87
Study: 8884623

Group type: EXPERIMENTAL
Intervention: Intravenous indomethacin 50 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1372124

Group type: COMPARATOR
Intervention: Iloprost (ZK 36 374) administered via infusion up to 12 ng kg-1 min-1 before and during ECC.
Number of subjects: 30
Study: 3979238

Group type: EXPERIMENTAL
Intervention: Cimetidine 300 mg qid
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg bid
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 30440010

Group type: EXPERIMENTAL
Intervention: Angola performance
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Benguela performance
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: São Bento performance
Number of subjects: 11
Study: 27199278

Group type: EXPERIMENTAL
Intervention: Hysteroscopy performed concurrently with oocyte retrieval (n = 150)
Number of subjects: 300

Group type: COMPARATOR
Intervention: ICSI freeze-all cycles without hysteroscopy (control group, n = 150)
Number of subjects: 300
Study: 24858963

Group type: EXPERIMENTAL
Intervention: 12.6% carbohydrate-containing drink (10 mL kg(‐1) the evening before surgery and two hours before anaesthesia)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fasting (Control Group 2)
Number of subjects: 20
Study: 22361576

Group type: EXPERIMENTAL
Intervention: Multidimensional Fatigue Inventory (MFI)
Number of subjects: 153
Study: 20120622

Group type: EXPERIMENTAL
Intervention: Patients with sleep disturbance prior to injury
Number of subjects: 1033

Group type: EXPERIMENTAL
Intervention: Patients with sleep disturbance prior to injury who had never experienced a prior disorder (n = 324)
Number of subjects: 1033

Group type: COMPARATOR
Intervention: Control group (patients without sleep disturbance prior to injury)
Number of subjects: 1033
Study: 18279765

Group type: EXPERIMENTAL
Intervention: Letrozole (aromatase inhibitor) as initial adjuvant therapy
Number of subjects: 0
Study: 15962646

Group type: EXPERIMENTAL
Intervention: Listening to a pre‐recorded explanation and music
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Propofol by patient‐controlled sedation (PCS)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110
Study: 12466363

Group type: EXPERIMENTAL
Intervention: hypocaloric diet + metformin
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 9989537

Group type: EXPERIMENTAL
Intervention: Home-based intervention (HBI)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 97
Study: 7591356

Group type: EXPERIMENTAL
Intervention: Weekly preannounced urine testing
Number of subjects: 74

Group type: COMPARATOR
Intervention: Weekly unannounced urine testing
Number of subjects: 74
Study: 2321612

Group type: EXPERIMENTAL
Intervention: Intensive postpartum education and support for breastfeeding
Number of subjects: 97

Group type: COMPARATOR
Intervention: Routine assistance provided by obstetrical nurses
Number of subjects: 97
Study: 87277

Group type: EXPERIMENTAL
Intervention: CHOP (cyclophosphamide, adriamycin, vincristine, and prednisone)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HOP (adriamycin, vincristine, and prednisone)
Number of subjects: 24

Group type: COMPARATOR
Intervention: COP plus bleomycin (cyclophosphamide, vincristine, prednisone, and bleomycin)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall (all treatments)
Number of subjects: 24
Study: 31478755

Group type: EXPERIMENTAL
Intervention: Probiotic (VISBIOME)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 28989802

Group type: EXPERIMENTAL
Intervention: Clopidogrel loading dose
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control (maintenance dose)
Number of subjects: 303
Study: 26621682

Group type: EXPERIMENTAL
Intervention: Estriol (8 mg daily) plus glatiramer acetate (20 mg daily)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo plus glatiramer acetate (20 mg daily)
Number of subjects: 164
Study: 25437725

Group type: EXPERIMENTAL
Intervention: One‐to‐one antenatal breastfeeding support and education session
Number of subjects: 469

Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 469
Study: 21257800

Group type: EXPERIMENTAL
Intervention: PM101 Premixed Injection (150 mg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Intravenous amiodarone (150 mg)
Number of subjects: 88
Study: 19190970

Group type: EXPERIMENTAL
Intervention: Ablation of Barrett's esophagus with Argon plasma coagulation (APC)
Number of subjects: 9
Study: 17971670

Group type: EXPERIMENTAL
Intervention: Electronically stored nosodes treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 15
Study: 15857878

Group type: EXPERIMENTAL
Intervention: Tracheobronchography
Number of subjects: 16

Group type: COMPARATOR
Intervention: Computed tomography (CT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Radiation doses
Number of subjects: 16

Group type: COMPARATOR
Intervention: Correlation between investigations
Number of subjects: 16
Study: 12032009

Group type: EXPERIMENTAL
Intervention: Oral tramadol 2 mg/kg
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Oral tramadol 1 mg/kg
Number of subjects: 81

Group type: COMPARATOR
Intervention: Rescue analgesia (morphine patient‐controlled analgesia or oral oxycodone)
Number of subjects: 81
Study: 9149248

Group type: EXPERIMENTAL
Intervention: Iodine-125 (125 I) brachytherapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control nonimplant group
Number of subjects: 24
Study: 8182225

Group type: EXPERIMENTAL
Intervention: Prophylactic group (breast milk from mothers on an exclusion diet or extensively hydrolyzed formula, acaricide treatment, polyvinyl-covered mattresses)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (conventional feeding, no environmental control)
Number of subjects: 120
Study: 3296668

Group type: EXPERIMENTAL
Intervention: Diuretic treatment
Number of subjects: 83

Group type: COMPARATOR
Intervention: Beta-blocker treatment
Number of subjects: 83
Study: 31098739

Group type: EXPERIMENTAL
Intervention: Colla corii asini (CCA) treatment, 15g daily for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Blank control group
Number of subjects: 20
Study: 30028477

Group type: EXPERIMENTAL
Intervention: Reflexology massage (two times for 20 min at 3-hour intervals)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo massage (unspecified point on the foot)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 75
Study: 27235524

Group type: EXPERIMENTAL
Intervention: Symptomatic treatment with a double elasticated bandage for four weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Immobilisation in a below-knee walking cast for four weeks
Number of subjects: 60
Study: 24604461

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT) in combination with systemic family therapy (SFT)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Conventional postpartum care
Number of subjects: 249
Study: 22650799

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine low dose (3 μg/kg/h for 10 min followed by 0.17 μg/kg/h for 50 min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine middle dose (6 μg/kg/h for 10 min followed by 0.34 μg/kg/h for 50 min)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine high dose (3.7 μg/kg/h for 35 min followed by 0.7 μg/kg/h for 25 min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20511126

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) at 20 Hz, 3 times per week for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 18584527

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy with indigocarmine
Number of subjects: 316

Group type: COMPARATOR
Intervention: Conventional colonoscopy (control)
Number of subjects: 316
Study: 16028125

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine (approximately 2 x 10^8 cfu)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (buffer only)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine
Number of subjects: 70
Study: 15548246

Group type: EXPERIMENTAL
Intervention: Verbal and written information in booklet form (experimental group)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Verbal information only (control group)
Number of subjects: 52
Study: 11100017

Group type: EXPERIMENTAL
Intervention: Calcitriol (0.75 microg/day for 6 months plus 1.25 microg/day for 3 months)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 27
Study: 9171252

Group type: EXPERIMENTAL
Intervention: Hawksley random zero sphygmomanometer (RZS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dinamap monitor
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 24-hour ambulatory blood pressure monitoring (ABPM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ABPM
Number of subjects: 40

Group type: COMPARATOR
Intervention: Overall blood pressure control
Number of subjects: 40

Group type: COMPARATOR
Intervention: Gender comparison
Number of subjects: 40
Study: 8403810

Group type: EXPERIMENTAL
Intervention: Peak flow variability index (highest peak flow variability within any 1 day during the 12‐day recording period, calculated as the difference between maximum and minimum peak flows expressed as a percentage of the minimum peak flow on that day)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Standard indices of mean peak flow, forced expiratory volume in 1.0 s, and responsiveness to salbutamol
Number of subjects: 147
Study: 2942753

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 2893527

Group type: EXPERIMENTAL
Intervention: Fenoldopam (1.45 +/- 1.66 micrograms/kg/min)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nitroprusside (2.99 +/- 1.59 micrograms/kg/min)
Number of subjects: 15
Study: 31196847

Group type: EXPERIMENTAL
Intervention: Ibrutinib (420 mg/d)
Number of subjects: 424
Study: 28917369

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (n=28)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham acupuncture (n=29)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard care (n=11)
Number of subjects: 68
Study: 25970511

Group type: EXPERIMENTAL
Intervention: Nap-group (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wake-group (n=40)
Number of subjects: 80
Study: 24156505

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Brief Relational Therapy
Number of subjects: 145
Study: 21726650

Group type: EXPERIMENTAL
Intervention: Mirtazapine (5-HT(2)/5-HT(3) receptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19497447

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 2342

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2342
Study: 16254269

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Low-dose perfluorocarbon (10 ml/kg)
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: High-dose perfluorocarbon (20 ml/kg)
Number of subjects: 311
Study: 15595715

Group type: EXPERIMENTAL
Intervention: Dipyrone (1 g, two 500 mg tablets)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 11424117

Group type: EXPERIMENTAL
Intervention: Triple antigen vaccine (Hepacare) - two-dose/1-month regimen
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Triple antigen vaccine (Hepacare) - three-dose/6-month regimen
Number of subjects: 303

Group type: COMPARATOR
Intervention: Single antigen vaccine (Recombivax-HB) - three-dose/6-month regimen
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Triple antigen vaccine (Hepacare) - three-dose/6-month regimen in at-risk adults
Number of subjects: 303
Study: 9024733

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg/day
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Simvastatin 160 mg/day
Number of subjects: 156
Study: 8331091

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 3653085

Group type: EXPERIMENTAL
Intervention: Suction catheter placed in the pharynx for scavenging nitrous oxide
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Inhalation anaesthetics during bronchoscopy
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia or local anaesthesia
Number of subjects: 14
Study: 29540326

Group type: EXPERIMENTAL
Intervention: Combination of rivaroxaban 2.5 mg twice daily and aspirin
Number of subjects: 6391

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 6391

Group type: EXPERIMENTAL
Intervention: MALE index event
Number of subjects: 6391
Study: 25820682

Group type: EXPERIMENTAL
Intervention: Transvaginal mesh repair
Number of subjects: 86
Study: 24390808

Group type: EXPERIMENTAL
Intervention: Weight training (2 days/week for 12 months)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Control (maintained usual physical activities)
Number of subjects: 258
Study: 23084789

Group type: EXPERIMENTAL
Intervention: DHEA 100 mg daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 20948589

Group type: EXPERIMENTAL
Intervention: Microdebrider-assisted partial turbinoplasty
Number of subjects: 268

Group type: COMPARATOR
Intervention: Radiofrequency-assisted partial turbinoplasty
Number of subjects: 268
Study: 17913498

Group type: EXPERIMENTAL
Intervention: Relatives' clinic offered to next-of-kin of Critical Care patients
Number of subjects: 321

Group type: COMPARATOR
Intervention: Control group (no relatives' clinic)
Number of subjects: 321
Study: 16972716

Group type: EXPERIMENTAL
Intervention: Adaptive designs in clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Confirmatory Seamless Phase II/III Clinical trials
Number of subjects: 0
Study: 12544908

Group type: EXPERIMENTAL
Intervention: PolyHeme
Number of subjects: 0

Group type: COMPARATOR
Intervention: PRBCs
Number of subjects: 0
Study: 10471431

Group type: EXPERIMENTAL
Intervention: Echovist with Valsalva maneuver
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Echovist with coughing
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Echovist with standardized Valsalva maneuver
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Saline with Valsalva maneuver
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Echovist
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: TCD with 2 provocation maneuvers using Echovist
Number of subjects: 46

Group type: COMPARATOR
Intervention: TCD
Number of subjects: 46